Expression of aberrantly spliced oncogenic Ikaros isoforms in childhood acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 17, Issue 12, 1999, Pages 3753-3766

  Sun, Lei ^a   Goodman, Patricia A ^a   Wood, Carla M ^a   Crotty, Mya Lisa ^a   Sensel, Martha ^a   Sather, Harland ^a   Navara, Christopher ^a   Nachman, James ^a   Steinherz, Peter G ^a   Gaynon, Paul S ^a   Seibel, Nita ^a   Vassilev, Alexei ^a   Juran, Brian D ^a   Reaman, Gregory H ^a   Uckun, Fatih M ^a  

^a Parker Hughes Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IKAROS; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALTERNATIVE RNA SPLICING; ARTICLE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032761116     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1999.17.12.3753     Document Type: Article

References (40)

1. Poplack D: Acute lymphoblastic leukemia, in Pizzo P, Poplack D (eds): Principles and Practice of Pediatric Oncology (ed 2). Philadelphia, PA, J.B. Lippincott, 1993, pp 431-482
2. Greaves MF: Differentiation linked leukemogenesis in lymphocytes. Science 234:697-704, 1986
3. Uckun FM, Sensel MG, Waddick KG, et al: Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. Blood 91:735-746, 1998
4. Crist WM, Shuster JJ, Falleta J, et al: Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: A Pediatric Oncology Group Study. Blood 72:1891-1897, 1988
5. Georgopoulos K, Bigby M, Wang JH, et al: The Ikaros gene is required for the development of all lymphopid lineages. Cell 79:143-156, 1994
6. Georgopoulos K, Moore DD, Derfler B: Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258:808-812, 1992
7. Hahm K, Ernst P, Lo K, et al: The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNA derived from the Ikaros gene. Mol Cell Biol 14:7111-7123, 1994
8. Molnar A, Georgopoulos K: The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 14:8292-8303, 1994
9. Wang JH, Nichogiannopoulos A, Wu L, et al: Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5:537-549, 1996
10. Winandy S, Wu P, Georgopoulos K: A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83:289-299, 1995
11. Molnar A, Wu P, Largespada DA, et al: The Ikaros gene encodes a family of lymphocyte restricted zinc finger DNA binding proteins, highly conserved in human and mouse. J Immunol 156:585-592, 1996
12. Sun L, Liu A, Georgopoulos K: Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 15:5358-5369, 1996
13. Hansen JD, Strassburger P, Du Pasquier L: Conservation of a master hematopoietic switch gene during vertebrate evolution: Isolation and characterization of Ikaros from teleost and amphibian species. Eur J Immunol 27:3049-3058, 1997
14. Georgopoulos K, Winandy S, Avitahl N: The role of the Ikaros gene in lymphocyte development and homeostasis. Ann Rev Immunol 15:155-176, 1997
15. Brown KE, Guest SS, Smale ST, et al: Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91:845-854, 1997
16. Klug CA, Morrison SJ, Masek M, et al: Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and karos is localized to heterochromatin in immature lymphocytes. Proc Natl Acad Sci U S A 95:657-662, 1998
17. Smith M, Arthur D, Camitta B, et al: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia [see comments]. J Clin Oncol 14:18-24, 1996
18. Uckun F Reaman G, Steinherz P, et al: Improved outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: A Children's Cancer Group Study. Leuk Lymphoma 24:57-70, 1996
19. Uckun FM, Sather HN, Gaynon P, et al: Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood 90:28-35, 1997
20. Uckun FM, Gaynon P, Sense M, et al: Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: A Children's Cancer Group Study. J Clin Oncol 15:2214-2221, 1997
21. + acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 73:1000-1015, 1989
22. Uckun FM, Dibirdik I, Smith R, et al: Interleukm 7 receptor ligation stimulates tyrosine phosphorylation inositol phospholipid turnover, and clonal proliferation of human B-cell precursors. Proc Natl Acad Sci U S A 88:3589-3593, 1991
23. Uckun FM, Herman-Hatten K, Crotty ML, et al: Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood 92:810-821, 1998
24. Uckun FM Waddick KG, Mahajan S, et al: BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 273:1096-1100, 1996
25. Sun L, Heerema N, Crotty L, et al: Expression of dominant-negative and mutant isoforms of the anti-leukemic transcription actor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 96-680-685, 1999
26. Nakayama H, Ishimaru F, Sezaki N, et al: Ikaros gene inactivation in patients with lymphoid crisis of chronic myelogenous leukemia. Blood 92:222a, 1998 (abstr 909) (suppl 1)
27. Morgan B, Sun L, Avitahl N, et al: Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J 16:2004-2013, 1997
28. Kelley CM, Ikeda T, Koipally J, et al: Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol 8:508-515, 1998
29. Hahm K, Cobb BS, McCarty AS, et al: Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev 12:782-796, 1998
30. Cote J, Chabot B: Natural base-pairing interactions between 5′ splice site and branch site sequences affect mammalian 5′ splice site selection. RNA 3:1248-1261, 1997
31. Smith CW, Nadal-Ginard B: Mutually exclusive splicing of alpha-tropomyosin exons enforced by an unusual lariat branch point location: Implications for constitutive splicing. Cell 56:749-758, 1989
32. Coolidge CJ, Seely RJ, Patton JG: Functional analysis of the polypyrimidine tract in pre-mRNA splicing. Nucleic Acids Res 25:888-896, 1997
33. Lopez AJ: Alternative splicing of pre-mRNA: Developmental consequences and mechanisms of regulation. Annu Rev Genet 32:279-305, 1998
34. Luo ZD, Camp S, Mutero A, et al: Splicing of 5′ introns dictates alternative splice selection of acetylcholinesterase pre-mRNA and specific expression during myogenesis. J Biol Chem 273:28486-28495, 1998
35. Schaal TD Maniatis T: Selection and characterization of pre-mRNA splicing enhancers: Identification of novel SR protein-specific enhancer sequences. Mol Cell Biol 19:1705-1719, 1999
36. Schaal TD, Maniatis T: Multiple distinct splicing enhancers in the protein-coding sequences of a constitutively spliced pre-mRNA. Mol Cell Biol 19:261-273, 1999
37. McCarthy EM, Phillips JA III: Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA. Hum Mol Genet 7:1491-1496, 1998
38. Burnette JM, Hatton AR, Lopez AJ: Trans-actmg factors required for inclusion of regulated exons in the Ultrabithorax mRNAs of Drosophila melanogaster. Genetics 151:1517-1529, 1999
39. Tamiya S, Etoh K-I, Suzushima H, et al: Mutation of CD95(Fas/Apo-1) gene in adult T-cell leukemia cells. Blood 91:3935-3942, 1998
40. Harada H, Kondo T, Ogawa S, et al: Accelerated exon skipping of IRF-1 mRNA in human myleodysplasia/leukemia: A possible mechanism of tumor suppressor inactivation. Oncogene 9:3313-3320, 1994